{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T11:56:37Z","timestamp":1778327797764,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32HL139426"],"award-info":[{"award-number":["T32HL139426"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K24HL155861"],"award-info":[{"award-number":["K24HL155861"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K01DK121825"],"award-info":[{"award-number":["K01DK121825"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK115534"],"award-info":[{"award-number":["R01DK115534"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s11606-024-08762-2","type":"journal-article","created":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T11:01:37Z","timestamp":1713524497000},"page":"1880-1886","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dihydropyridine Calcium Channel Blockers and Kidney Outcomes"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4357-6926","authenticated-orcid":false,"given":"Matthew F.","family":"Blum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya","family":"Surapaneni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley A.","family":"Inker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa K.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence J.","family":"Appel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Im","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan E.","family":"Grams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,19]]},"reference":[{"key":"8762_CR1","doi-asserted-by":"publisher","unstructured":"Casey DE, Karen Collins Faha J, Cheryl Dennison Himmelfarb Mba, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: a Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127-e248. https:\/\/doi.org\/10.1016\/J.JACC.2017.11.006","DOI":"10.1016\/J.JACC.2017.11.006"},{"key":"8762_CR2","unstructured":"Guideline for the Pharmacological Treatment of Hypertension in Adults. World Health Organization; 2021. Accessed January 6, 2023. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK573631\/"},{"issue":"5","key":"8762_CR3","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/jch.13280","volume":"20","author":"MG Jaffe","year":"2018","unstructured":"Jaffe MG, Frieden TR, Campbell NRC, et al. Recommended Treatment Protocols to Improve Management of Hypertension Globally: a Statement by Resolve to Save Lives and the World Hypertension League (WHL). J Clin Hypertens Greenwich Conn. 2018;20(5):829-836. https:\/\/doi.org\/10.1111\/jch.13280","journal-title":"J Clin Hypertens Greenwich Conn."},{"issue":"10","key":"8762_CR4","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1093\/ajh\/hpx085","volume":"30","author":"SJ Shah","year":"2017","unstructured":"Shah SJ, Stafford RS. Current Trends of Hypertension Treatment in the United States. Am J Hypertens. 2017;30(10):1008-1014. https:\/\/doi.org\/10.1093\/ajh\/hpx085","journal-title":"Am J Hypertens."},{"issue":"1","key":"8762_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1161\/HYPERTENSIONAHA.120.15462","volume":"77","author":"J An","year":"2021","unstructured":"An J, Luong T, Qian L, et al. Treatment Patterns and Blood Pressure Control With Initiation of Combination Versus Monotherapy Antihypertensive Regimens. Hypertension. 2021;77(1):103-113. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.15462","journal-title":"Hypertension."},{"key":"8762_CR6","doi-asserted-by":"publisher","unstructured":"Derington CG, King JB, Herrick JS, et al. Trends in Antihypertensive Medication Monotherapy and Combination Use Among US Adults, National Health and Nutrition Examination Survey 2005\u20132016. Hypertension. Published online 2020:973-981. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.14360","DOI":"10.1161\/HYPERTENSIONAHA.119.14360"},{"issue":"4","key":"8762_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/hr.2010.259","volume":"34","author":"JG Wang","year":"2011","unstructured":"Wang JG, Kario K, Lau T, et al. Use of Dihydropyridine Calcium Channel Blockers in the Management of Hypertension in Eastern Asians: a Scientific Statement from the Asian Pacific Heart Association. Hypertens Res. 2011;34(4):423-430. https:\/\/doi.org\/10.1038\/hr.2010.259","journal-title":"Hypertens Res."},{"issue":"10285","key":"8762_CR8","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","volume":"397","author":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration","year":"2021","unstructured":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration. Pharmacological Blood Pressure Lowering for Primary and Secondary Prevention of Cardiovascular Disease Across Different Levels of Blood Pressure: an Individual Participant-Level Data Meta-Analysis. Lancet. 2021;397(10285):1625-1636. https:\/\/doi.org\/10.1016\/S0140-6736(21)00590-0","journal-title":"Lancet."},{"issue":"3","key":"8762_CR9","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1161\/01.RES.0000256155.31133.49","volume":"100","author":"K Hayashi","year":"2007","unstructured":"Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T. Ca2+ Channel Subtypes and Pharmacology in the Kidney. Circ Res. 2007;100(3):342-353. https:\/\/doi.org\/10.1161\/01.RES.0000256155.31133.49","journal-title":"Circ Res."},{"issue":"9731","key":"8762_CR10","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"K Matsushita","year":"2010","unstructured":"Matsushita K, van der Velde M, Astor BC, et al. Association of Estimated Glomerular Filtration Rate and Albuminuria with All-Cause and Cardiovascular Mortality in General Population Cohorts: a Collaborative Meta-Analysis. Lancet. 2010;375(9731):2073-2081. https:\/\/doi.org\/10.1016\/S0140-6736(10)60674-5","journal-title":"Lancet."},{"key":"8762_CR11","doi-asserted-by":"publisher","unstructured":"Gansevoort RT, Matsushita K, Van Der Velde M, et al. Lower Estimated GFR and Higher Albuminuria Are Associated with Adverse Kidney Outcomes. A Collaborative Meta-Analysis of General and High-Risk Population Cohorts. Kidney Int. 2011;80(1):93-104. https:\/\/doi.org\/10.1038\/KI.2010.531","DOI":"10.1038\/KI.2010.531"},{"issue":"4","key":"8762_CR12","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1681\/ASN.2008060655","volume":"20","author":"MD Van Velde","year":"2009","unstructured":"Van Velde MD, Halbesma N, De Charro FT, et al. Screening for Albuminuria Identifies Individuals at Increased Renal Risk. J Am Soc Nephrol. 2009;20(4):852-862. https:\/\/doi.org\/10.1681\/ASN.2008060655","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"8762_CR13","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1681\/ASN.2005091012","volume":"17","author":"A Ishani","year":"2006","unstructured":"Ishani A, Grandits GA, Grimm RH, et al. Association of Single Measurements of Dipstick Proteinuria, Estimated Glomerular Filtration Rate, and Hematocrit with 25-Year Incidence of End-Stage Renal Disease in the Multiple Risk Factor Intervention Trial. J Am Soc Nephrol. 2006;17(5):1444-1452. https:\/\/doi.org\/10.1681\/ASN.2005091012","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"8762_CR14","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1172\/JCI118125","volume":"96","author":"KA Griffin","year":"1995","unstructured":"Griffin KA, Picken MM, Bidani AK. Deleterious Effects of Calcium Channel Blockade on Pressure Transmission and Glomerular Injury in Rat Remnant Kidneys. J Clin Invest. 1995;96(2):793-800. https:\/\/doi.org\/10.1172\/JCI118125","journal-title":"J Clin Invest."},{"issue":"5","key":"8762_CR15","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.2215\/CJN.02231205","volume":"1","author":"KA Griffin","year":"2006","unstructured":"Griffin KA, Bidani AK. Progression of Renal Disease: Renoprotective Specificity of Renin-Angiotensin System Blockade. Clin J Am Soc Nephrol. 2006;1(5):1054-1065. https:\/\/doi.org\/10.2215\/CJN.02231205","journal-title":"Clin J Am Soc Nephrol."},{"issue":"6","key":"8762_CR16","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1111\/J.1523-1755.2004.00620.X","volume":"65","author":"GL Bakris","year":"2004","unstructured":"Bakris GL, Weir MR, Secic M, Campbell B, Weis-McNulty A. Differential Effects of Calcium Antagonist Subclasses on Markers of nephropathy Progression. Kidney Int. 2004;65(6):1991-2002. https:\/\/doi.org\/10.1111\/J.1523-1755.2004.00620.X","journal-title":"Kidney Int."},{"issue":"19","key":"8762_CR17","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1001\/JAMA.288.19.2421","volume":"288","author":"JT Wright","year":"2002","unstructured":"Wright JT, Bakris G, Greene T, et al. Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease: Results From the AASK Trial. JAMA. 2002;288(19):2421-2431. https:\/\/doi.org\/10.1001\/JAMA.288.19.2421","journal-title":"JAMA."},{"issue":"6","key":"8762_CR18","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2215\/CJN.07800811","volume":"7","author":"M Rahman","year":"2012","unstructured":"Rahman M, Ford CE, Cutler JA, et al. Long-Term Renal and Cardiovascular Outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants by Baseline Estimated GFR. Clin J Am Soc Nephrol. 2012;7(6):989-1002. https:\/\/doi.org\/10.2215\/CJN.07800811","journal-title":"Clin J Am Soc Nephrol."},{"issue":"8","key":"8762_CR19","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1001\/ARCHINTE.165.8.936","volume":"165","author":"M Rahman","year":"2005","unstructured":"Rahman M, Pressel S, Davis BR, et al. Renal Outcomes in High-Risk Hypertensive Patients Treated with an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker vs a Diuretic: a Report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med. 2005;165(8):936-946. https:\/\/doi.org\/10.1001\/ARCHINTE.165.8.936","journal-title":"Arch Intern Med."},{"issue":"23","key":"8762_CR20","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1001\/JAMA.288.23.2981","volume":"288","author":"CD Furberg","year":"2002","unstructured":"Furberg CD, Wright JT, Davis BR, et al. Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981-2997. https:\/\/doi.org\/10.1001\/JAMA.288.23.2981","journal-title":"JAMA."},{"issue":"6","key":"8762_CR21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.7326\/M20-0529\/SUPPL_FILE\/M20-0529_SUPPLEMENT.PDF","volume":"173","author":"K Sumida","year":"2020","unstructured":"Sumida K, Nadkarni GN, Grams ME, et al. Conversion of Urine Protein\u2013Creatinine Ratio or Urine Dipstick Protein to Urine Albumin\u2013Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis: an Individual Participant\u2013Based Meta-Analysis. Ann Intern Med. 2020;173(6):426-435. https:\/\/doi.org\/10.7326\/M20-0529\/SUPPL_FILE\/M20-0529_SUPPLEMENT.PDF","journal-title":"Ann Intern Med."},{"issue":"19","key":"8762_CR22","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMOA2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, et al. New Creatinine- and Cystatin C-Based Equations to Estimate GFR Without Race. N Engl J Med. 2021;385(19):1737-1749. https:\/\/doi.org\/10.1056\/NEJMOA2102953","journal-title":"N Engl J Med."},{"issue":"5","key":"8762_CR23","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1001\/jamainternmed.2020.0193","volume":"180","author":"Y Qiao","year":"2020","unstructured":"Qiao Y, Shin JI, Chen TK, et al. Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate. JAMA Intern Med. 2020;180(5):718-726. https:\/\/doi.org\/10.1001\/jamainternmed.2020.0193","journal-title":"JAMA Intern Med."},{"key":"8762_CR24","unstructured":"Rubin D. Multiple Imputation for Nonresponse in Surveys. (John Wiley & Sons, ed.).; 2004. https:\/\/books.google.com\/books?hl=en&lr=&id=bQBtw6rx_mUC&oi=fnd&pg=PR24&ots=8PuF5L6ZhQ&sig=BUDoFYT3Bq6ietIx4aV6xUyOVHI"},{"issue":"4","key":"8762_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","volume":"139","author":"TH Jafar","year":"2003","unstructured":"Jafar TH, Stark PC, Schmid CH, et al. Progression of Chronic Kidney Disease: the Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: a Patient-Level Meta-Analysis. Ann Intern Med. 2003;139(4). https:\/\/doi.org\/10.7326\/0003-4819-139-4-200308190-00006","journal-title":"Ann Intern Med."},{"issue":"2","key":"8762_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.7326\/0003-4819-135-2-200107170-00007","volume":"135","author":"TH Jafar","year":"2001","unstructured":"Jafar TH, Schmid CH, Landa M, et al. Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal Disease. A Meta-Analysis of Patient-Level Data. Ann Intern Med. 2001;135(2):73-87. https:\/\/doi.org\/10.7326\/0003-4819-135-2-200107170-00007","journal-title":"Ann Intern Med."},{"issue":"7","key":"8762_CR27","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/SJ.KI.5002773","volume":"73","author":"P Hart","year":"2008","unstructured":"Hart P, Bakris GL. Calcium Antagonists: Do They Equally Protect Against Kidney Injury? Kidney Int. 2008;73(7):795-796. https:\/\/doi.org\/10.1038\/SJ.KI.5002773","journal-title":"Kidney Int."},{"issue":"1","key":"8762_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000499486","volume":"143","author":"A Chagnac","year":"2019","unstructured":"Chagnac A, Zingerman B, Rozen-Zvi B, Herman-Edelstein M. Consequences of Glomerular Hyperfiltration: the Role of Physical Forces in the Pathogenesis of Chronic Kidney Disease in Diabetes and Obesity. Nephron. 2019;143(1):38-42. https:\/\/doi.org\/10.1159\/000499486","journal-title":"Nephron."},{"issue":"5","key":"8762_CR29","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1046\/J.1523-1755.1999.00434.X","volume":"55","author":"KA Griffin","year":"1999","unstructured":"Griffin KA, Picken MM, Bakris GL, Bidani AK. Class Differences in the Effects of Calcium Channel Blockers in the Rat Remnant Kidney Model. Kidney Int. 1999;55(5):1849-1860. https:\/\/doi.org\/10.1046\/J.1523-1755.1999.00434.X","journal-title":"Kidney Int."},{"issue":"6","key":"8762_CR30","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1053\/J.AJKD.2016.12.017","volume":"69","author":"AD Moes","year":"2017","unstructured":"Moes AD, Hesselink DA, van den Meiracker AH, Zietse R, Hoorn EJ. Chlorthalidone Versus Amlodipine for Hypertension in Kidney Transplant Recipients Treated With Tacrolimus: a Randomized Crossover Trial. Am J Kidney Dis. 2017;69(6):796-804. https:\/\/doi.org\/10.1053\/J.AJKD.2016.12.017","journal-title":"Am J Kidney Dis."},{"issue":"5","key":"8762_CR31","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1046\/J.1523-1755.2000.00031.X","volume":"57","author":"MW Taal","year":"2000","unstructured":"Taal MW, Brenner BM. Renoprotective Benefits of RAS Inhibition: from ACEI to Angiotensin II Antagonists. Kidney Int. 2000;57(5):1803-1817. https:\/\/doi.org\/10.1046\/J.1523-1755.2000.00031.X","journal-title":"Kidney Int."},{"issue":"12","key":"8762_CR32","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/S0895-7061(02)03017-0","volume":"15","author":"R Fogari","year":"2002","unstructured":"Fogari R, Preti P, Zoppi A, et al. Effects of Amlodipine Fosinopril Combination on Microalbuminuria in Hypertensive Type 2 Diabetic Patients. Am J Hypertens. 2002;15(12):1042-1049. https:\/\/doi.org\/10.1016\/S0895-7061(02)03017-0","journal-title":"Am J Hypertens."},{"issue":"9721","key":"8762_CR33","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0140-6736(09)62100-0","volume":"375","author":"GL Bakris","year":"2010","unstructured":"Bakris GL, Sarafidis PA, Weir MR, et al. Renal Outcomes with Different Fixed-Dose Combination Therapies in Patients with Hypertension at High Risk for Cardiovascular Events (ACCOMPLISH): a Prespecified Secondary Analysis of a Randomised Controlled Trial. Lancet. 2010;375(9721):1173-1181. https:\/\/doi.org\/10.1016\/S0140-6736(09)62100-0","journal-title":"Lancet."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-024-08762-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-024-08762-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-024-08762-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T18:05:37Z","timestamp":1764266737000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-024-08762-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,19]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["8762"],"URL":"https:\/\/doi.org\/10.1007\/s11606-024-08762-2","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,19]]},"assertion":[{"value":"13 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"Dr. Blum reports grants or contracts: National Kidney Foundation and Johns Hopkins University; meeting or travel support: American Society of Nephrology. Dr. Chang reports grants or contracts: Bayer, Novartis, Novo Nordisk; consulting fees: Novartis, Reata, Amgen; data safety monitoring board or advisory board: Occurrence of Dyskalemia with Treatment for Hypertension Study. Dr. Inker reports grants or contracts: National Kidney Foundation, National Institutes of Health, Omeros, Dialysis Clinics Inc., Reata; consulting fees: Tufts Medical Center; data safety monitoring board or advisor board: Dimerix, TMC, Tricida, Healthlogistics. Dr. Chen reports grants or contracts: National Institutes of Health, Yale University; payment or honoraria: American Society of Nephrology; meeting or travel support: CKD Biomarkers Consortium Meeting. Dr. Grams reports grants or contracts: National Institutes of Health and National Kidney Foundation; payment or honoraria: University of Pennsylvania, Columbia University Medical Center, American Society of Nephrology; meeting\/travel support: Kidney Disease Improving Global Outcomes, European Renal Association, University of Pennsylvania, and Korean Society of Nephrology; leadership or fiduciary role: American Society of Nephrology, Kidney Disease: Improving Global Outcomes, National Kidney Foundation, United States Renal Data System, American Society of Clinical Investigation, Clinical Journal of American Society of Nephrology, American Journal of Kidney Diseases, and Journal of American Society of Nephrology. The remaining authors declare that they have no relevant financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest:"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}